These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7898728)

  • 21. Carrier detection in ornithine transcarbamylase deficiency.
    Hokanson JT; O'Brien WE; Idemoto J; Schafer IA
    J Pediatr; 1978 Jul; 93(1):75-8. PubMed ID: 650350
    [No Abstract]   [Full Text] [Related]  

  • 22. [Neonatal hyperammonemia due to ornithine transcarbamylase deficiency (author's transl)].
    del Valle JA; Urbón A; García MJ; Cuadrado P; Ugarte M
    An Esp Pediatr; 1982 May; 16(5):416-20. PubMed ID: 7114619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapy of hyperammonemia due to ornithine transcarbamylase defiency in a male neonate.
    Snyderman SE; Sansaricq C; Phansalkar SV; Schacht RC; Norton PM
    Pediatrics; 1975 Jul; 56(1):65-73. PubMed ID: 1153252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.
    Batshaw ML; Roan Y; Jung AL; Rosenberg LA; Brusilow SW
    N Engl J Med; 1980 Feb; 302(9):482-5. PubMed ID: 7351973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hyperammonemia in the newborn through ornithine transcarbamylase deficiency (author's transl)].
    Plöchl E; Hilbe W; Bachmann C
    Padiatr Padol; 1981; 16(2):179-88. PubMed ID: 7243329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient.
    Heringlake S; Böker K; Manns M
    Digestion; 1997; 58(1):83-6. PubMed ID: 9018015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ornithine transcarbamylase deficiency: ten new mutations and high proportion of de novo mutations in heterozygous females.
    Oppliger Leibundgut E; Liechti-Gallati S; Colombo JP; Wermuth B
    Hum Mutat; 1997; 9(5):409-11. PubMed ID: 9143919
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies of the cause and treatment of hyperammonemia in females with ornithine transcarbamylase deficiency.
    Glasgow AM; Kraegel JH; Schulman JD
    Pediatrics; 1978 Jul; 62(1):30-7. PubMed ID: 683780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal treatment of ornithine transcarbamylase deficiency.
    Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
    Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproate-induced hyperammonemia in asymptomatic children.
    Wyllie E; Wyllie R; Rothner AD; Erenberg G; Cruse RP
    Cleve Clin Q; 1983; 50(3):275-7. PubMed ID: 6418412
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe cerebral damage in ornithine transcarbamylase deficiency.
    Dolman CL; Clasen RA; Dorovini-Zis K
    Clin Neuropathol; 1988; 7(1):10-5. PubMed ID: 3370859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ornithine transcarbamylase deficiency diagnosed in pregnancy.
    Celik O; Buyuktas D; Aydin A; Acbay O
    Gynecol Endocrinol; 2011 Dec; 27(12):1052-4. PubMed ID: 21736537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organic acid metabolism in a patient with ornithine transcarbamylase deficiency.
    Kodama H; Nose O; Okada S; Maki I; Tajiri H; Sano T; Yabuuchi H
    Clin Chim Acta; 1982 Aug; 123(1-2):83-91. PubMed ID: 7116641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of ornithine transcarbamylase deficiency associated with a minor epileptic status].
    Kai Y; Taku K; Ohtani Y; Miike T; Miyazaki T; Haraguchi Y; Hattori R
    No To Hattatsu; 1987 May; 19(3):239-43. PubMed ID: 3580204
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: Case of hyperammonaemia due to ornithine transcarbamylase deficiency.
    Morley C; Sardharwalla IB
    Arch Dis Child; 1974 Sep; 49(9):747. PubMed ID: 4419328
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neutropenia during treatment with valproate].
    Jensen NB; Storm K
    Ugeskr Laeger; 1987 Mar; 149(10):664. PubMed ID: 3107182
    [No Abstract]   [Full Text] [Related]  

  • 37. Ornithine transcarbamylase deficiency. Unsuccessful therapy of neonatal hyperammonemia with N-carbamyl-L-glutamate and L-arginine.
    Gelehrter TD; Rosenberg LE
    N Engl J Med; 1975 Feb; 292(7):351-2. PubMed ID: 1117963
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperaminoacidemia in epileptic children treated with valproic acid.
    Castro-Gago M; Rodrigo-Saez E; Novo-Rodriguez I; Camiña MF; Rodriguez-Segade S
    Childs Nerv Syst; 1990 Dec; 6(8):434-6. PubMed ID: 2095300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunochemical study of ornithine transcarbamylase deficiency.
    Kodama H; Nagayama H; Shimoizumi H; Okabe I; Kamoshita S
    J Inherit Metab Dis; 1984; 7(3):131-2. PubMed ID: 6438397
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hyperammonemia due to ornithine transcarbamylase deficiency--a cause of lethal metabolic crisis during the newborn period and infancy (author's transl)].
    Schuchmann L; Colombo JP; Fischer H
    Klin Padiatr; 1980 May; 192(3):281-5. PubMed ID: 7191930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.